Remote prescribing of cosmetic injectables is set to be banned within weeks in a landmark move to better protect the public.

From 1 June, anyone seeking treatment such as botulinum toxin or fillers must have a direct appointment with a medical professional.

Before now, substances used in these types of non-surgical cosmetic procedures (NSCPs) could be prescribed to non-medical practitioners without the need to meet with the individual it is being used on.

The practice has been highlighted as a grey area in regulations that can put people at greater risk of botched treatments.

The British Beauty Council, of which Cosmetics Business is a patron, has backed calls for tighter regulation for years along with others in the industry, including the Joint Council for Cosmetic Practitioners (JCCP), and both have welcomed the move.

The Nursing and Midwifery Council (NMC) has updated its position on the practice after launching research into the issue last year.

Nurse or midwife prescribers must have a face-to-face meeting with the intended recipient before prescribing any products used for elective NSPCs.

Remote methods such as telephone, email, online, video or communication via a third-party will not be allowed.

They must undertake and document an appropriate clinical assessment with the recipient, at initial consultation and subsequent ones, including follow-ups.

Read more: click here